Mahamaya Lifesciences Limited (BOM:544611)
India · Delayed Price · Currency is INR 181.15
-5.85 (-3.13%)
At close: Oct 15, 2026
Mahamaya Lifesciences Revenue
In the fiscal year ending March 31, 2026, Mahamaya Lifesciences had annual revenue of 3.29B INR with 24.10% growth. Mahamaya Lifesciences had revenue of 1.66B in the half year ending March 31, 2026. That makes Mahamaya Lifesciences the 30,541st largest company in the world by revenue and 2,115th in India.
Revenue
3.29B
Revenue Growth
+24.10%
P/S Ratio
1.29
Revenue / Employee
46.37M
Employees
71
Market Cap
4.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.29B | 639.31M | 24.10% |
| Mar 31, 2025 | 2.65B | 1.04B | 64.18% |
| Mar 31, 2024 | 1.62B | 244.69M | 17.84% |
| Mar 31, 2023 | 1.37B | 472.02M | 52.49% |
| Mar 31, 2022 | 899.19M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Southern Petrochemical Industries Corporation | 30.24B |
| Best Agrolife | 12.72B |
| Excel Industries | 10.79B |
| Khaitan Chemicals and Fertilizers | 9.88B |
| Rama Phosphates | 9.28B |
| Aries Agro | 7.66B |
| Shivalik Rasayan | 3.75B |
| Kothari Industrial Corporation | 1.95B |